22 Jul Precigen
Helen Sabzevari, Ph.D., President and CEO
Precigen is a dedicated discovery and clinical-stage biopharmaceutical company advancing the next-generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated, unique therapies toward clinical proof-of-concept and commercialization.